Detecting 72 genes most commonly mutated in lung cancer

Detecting 72 genes most commonly mutated in lung cancer

Anatomy - Pathology / Cytogenetics / Molecular Diagnostics

December 14, 2016

Interested in the simultaneous detection of 72 genes most commonly mutated in lung cancer with high confidence? The newly developed Human Lung Cancer QIAseq DNA Panel provides you with a complete Sample to Insight solution and a simple, streamlined workflow.

The panel combines single primer extension (SPE) technology and unique molecular indices (UMIs) to enable sequencing of GC-rich regions, direct quantitation of CNVs, accurate expression level measurement and variant call validation. The simplicity of the system makes it ideal for routine known and novel lung cancer mutation detection on any NGS platform from Illumina and Ion Torrent.

NEW QIAstat-Dx Respiratory 2019-nCoV Panel

NEW QIAstat-Dx Respiratory 2019-nCoV Panel

Anatomy - Pathology / Cytogenetics / Molecular Dia...

To support the research efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN® developed the QIAstat-Dx® Respiratory 2019-nCoV Panel.

December 18, 2020 More +
New MASTR Facility supports adoption of NGS

New MASTR Facility supports adoption of NGS

Anatomy - Pathology / Cytogenetics / Molecular Dia...

Multiplicom is pleased to announce the new MASTR Facility to enable the implementation of massively parallel sequencing capabilities in clinical genetics and pathology laboratories.

September 15, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us